Table 3 Short and long-term outcomes post-TAVR
Outcomesa | All Subjects (n = 610) | Non- XRT Group (n = 535) | C-XRT Group (n = 75) | P value |
|---|---|---|---|---|
Early Events | ||||
 ICU LOS (hrs) | 41.9 ± 43.1 | 41.50 ± 43.19 | 44.67 ± 43.00 | 0.55 |
 Hospital LOS (days) | 5.2 ± 6.5 | 5.32 ± 6.84 | 4.52 ± 3.64 | 0.31 |
 In Hospital AMI | 1 (0.16) | 1 (0.19) | 0 (0) | 1.0 |
 In Hospital AF | 49 (8.03) | 13 (2.43) | 36 (48.00) | < 0.0001 |
 In Hospital stroke | 9 (1.48) | 5 (0.93) | 4 (5.33) | 0.01 |
 In Hospital cardiac arrest | 20 (3.28) | 15 (2.80) | 5 (6.67) | 0.08 |
 In Hospital Mortality | 17 (2.79) | 12 (2.24) | 5 (6.67) | 0.04 |
 30-day Mortality | 17 (2.79) | 12 (2.24) | 5 (6.67) | 0.04 |
 Major bleed | 63 (10.33) | 52 (9.72) | 11 (14.67) | 0.22 |
Long-term Events | ||||
 AMI and/or urgent PCI | 35 (5.74) | 31 (5.79) | 4 (5.33) | 1.00 |
 Stroke/TIA | 36 (5.90) | 27 (5.05) | 9 (12.00) | 0.03 |
 HF admission | 113 (18.52) | 90 (16.82) | 23 (30.67) | 0.006 |
 PPM implants | 64 (10.49) | 49 (9.16) | 15 (20.0) | 0.007 |
 CV Mortality | 50 (48.54) | 36 (44.44) | 14 (63.64) | 0.14 |
 All-Cause Mortality | 103 (16.89) | 81 (15.14) | 22 (29.33) | 0.004 |
 MACE | 185 (30.33) | 144 (26.92) | 41 (54.67) | < 0.0001 |
Quality of Life measures | ||||
 Home Disposition post TAVR | 513 (84.10) | 451 (84.30) | 62 (82.67) | 0.73 |
 KCCQ12 at 30 days | 79.23 ± 17.11 | 79.27 ± 16.98 | 78.96 ± 18.20 | 0.88 |
 KCCQ12 at 1 year | 83.02 ± 13.47 | 82.86 ± 13.55 | 84.29 ± 12.81 | 0.44 |